Research Development on Tibetan Medicine Prevention and Treatment of High Altitude Polycythemia
10.11842/wst.2015.05.023
- VernacularTitle:藏医药防治高原红细胞增多症的研究进展＊
- Author:
Yu HUANG
;
Xianrong LAI
;
Luo DE
;
Tingting KUANG
;
Jing ZHANG
;
Yujie WANG
;
Wenbin WU
;
Yi ZHANG
- Publication Type:Journal Article
- Keywords:
Tibetan medicine;
high altitude polycythemia;
inheritance and innovation;
systems biology
- From:
World Science and Technology-Modernization of Traditional Chinese Medicine
2015;(5):1042-1046
- CountryChina
- Language:Chinese
-
Abstract:
High altitude polycythemia (HAPC) had become one of the main common chronic diseases, which had seriously threatened the health of Plateau people. In the Tibetan medicine classic bookSi-Bu Yi-Dian, there were recordings on HAPC treatment methods and medications, which had the unique advantages of identified therapeutic effect with little side effect. This article analyzed Tibetan medicine in the prevention and treatment of HAPC from aspects such as etiology and pathogenesis, clinical treatment advantages and modern innovation study. Questions were also raised on lacking of standardization on HAPC clinical effectiveness, as well as Tibetan medicine compound material basis and action mechanisms were unclear. It was proposed that based on the inheritance of Tibetan medicine theoretical basis and clinical therapeutic effect, the Tibetan medicine original thinking should be combined with modern science and technology, in order to strengthen the analysis of ancient literature collection in HAPC treatment and data mining in medication experiences. The clinical treatment standards and medication plan should be standardized. Methods of systems biology, such as metabolomics, can be used in the further study of the scientific connotation of HAPC treatment by Tibetan medicine.
